When does xarelto become generic?

Let’s face it, we all want to save a buck or two. And when it comes to prescription medications, there’s always the hope that our beloved pill will become available in a less expensive generic form. In this article, we’ll be discussing Xarelto and when you can expect it to go generic.

What is Xarelto?

Xare-what? If you’re not familiar with this medication, then allow me to enlighten you. Xarelto (rivaroxaban) is an anticoagulant used for preventing blood clots in patients who have undergone hip or knee replacement surgery or are at risk of developing deep vein thrombosis (DVT) or pulmonary embolism (PE).

Now that we’ve got the basics out of the way, let’s discuss what everyone really wants to know: when can we expect a cheaper version of this wonder drug?

The Story So Far

Before jumping into predictions about generics entering the market, history should be taken into account – especially when considering high-profile drugs like Xarelto.

Johnson & Johnson, who owns Janssen Pharmaceuticals –makers of Xarelto– has had no shortage of litigious disputes over their blockbuster drug; from allegations surrounding clinical trials data manipulation claims by consumers regarding severe bleeding events during use – as well as running fraudulent free samples program alongside its pharmaceutical co-marketers Bayer AG.

These legal fights notwithstanding though JS&J continue till date unrelenting churning profitability through sales making Rivaroxaban one hot commodity destined for lesser profit erosion for potential entrants upon going off-brand er thereby becoming more accesible affordability wise without health insurance coverages necessarily differing profit margins compared with similar anti-coagulants already out there could make such approvals unlikely outcomes anytime soon unseen by current industry forecasters according recent findings published across reliable sources over the internet.

So, When Does Xarelto Actually Go Generic?

Now that we’ve got the background out of the way – let’s try to answer the million-dollar question on everyone’s lips.

The short answer: we’re not entirely sure when generic Xarelto will become available, but there are a few things worth noting about how generics enter onto markets generally.

Generally drug becomes eligible for unit price erosion after it loses market exclusivity once their patent expires then manufacturers flood-in end rapidly expand gradually shooting down off-brand makers and being benefited greatly as brands also lower prices themselves in anticipation thereby prompting rigidity in ongoing legal battles over clinical trial biases such as e.g. NSCLC or renal clearance adjustment concerns leading mismatches against what is claimed on-package labels whilst leaving firms with lost opportunities expensive litigation fees overall!

Upon loss of its provisional patent rights date which occured this November 4th 2019 soon branded versions can start seeing substantial reduced-cost competition statistically pioneering pioneers Pfizer & BMS–have had pricing-pressure implications by GreenstoneLLC amid PDUFA’s incoming ability to bring noninfringing IR formulation equivalents thereof since drug-makers filing for ANDA approval may need expeditted FDA review just like previously approved similar anti-coagulants seeking ANVISA approvals too based upon product-differentiations highlighting Sildenafil-citrate constituent-contents v.s. Rivaroxaban within compounds too; making direct substitution more challenging than ever before unlike peripheral-causal-variances conventional local-pharmacists usually take into consideration first.

While many have speculated that generics could hit pharmacy shelves shortly thereafter – especially given prior successes with Baraclude (J&J) – others think we may be waiting until at least late 2020 (if not later!) To make matters worse, huge backlog of applications pending approval means possibility has slowed down shipment schedules enough possible industry mergers/such so-called drug-sharing arrangements.

All of this means that unfortunately at best, we should just sit tight and be patient. While there’s no way to say for certain when the generic version will hit the market, rest assured it will come eventually – until then you may want to inquire about discount coupon programs by Walgreens or Rite Aid nearest branch offices among other similar drugstore chains alternatives available near you too!

Dane Raynor

Hey there, I’m Dane Raynor, and I’m all about sharing fascinating knowledge, news, and hot topics. I’m passionate about learning and have a knack for simplifying complex ideas. Let’s explore together!